A new study by researchers at Northwestern University's Feinberg School of Medicine may change current thinking about how best to treat patients in respiratory distress in hospital intensive care units.

A new classification system of rare lung diseases in infants is improving diagnosis and treatment. The system clears up considerable confusion about how to classify and treat diseases that are rarely seen by most doctors and pathologists, says Gail H. Deutsch, M.D., lead author of the multi-center study that developed the new guidelines.

The acute respiratory distress syndrome (ARDS), a clinical complication of severe acute lung injury (ALI) in humans, is a leading cause of morbidity and mortality in critically ill patients.

Major U.S. academic medical centers can successfully—and safely—integrate minimally invasive lung surgery into their training programs with a standardized, step-by-step plan, according to University of Cincinnati (UC) thoracic surgeons.

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly.

Researchers from Massachusetts General Hospital, in collaboration with scientists from the Genzyme Corporation, have identified a potential treatment for a chronic lung disease affecting premature infants.